Skip to main content

Global Dermal Fillers Market to Hit USD 6,303.2 Million and Exhibit 7.8% CAGR by 2026, Rising Awareness about Dermal Filler Treatment Spikes its Demand: Fortune Business Insights™

Written by Customer Service on . Posted in Mergers And Acquisitions.

Pune, India, Dec. 15, 2020 (GLOBE NEWSWIRE) — The rising demand for minimally-invasive procedures aiding the growth of the global dermal fillers market.  The global market will rise at a CAGR of 7.8% during the forecast period, 2019-2016. The growing awareness about dermal fillers treatment in developed as well as developing countries will help the market reach USD 6,303.2 Million by 2026. Furthermore, the global market was worth USD 3,471.5 Million in 2018.  The market in North America was worth US$ 1,596.8 Mn. Driven by the growing demand for innovative and advanced dermal fillers, the region is expected to lead global market through the forecast years.Key Industry Developments:In April 2019, Merz Pharma announced the launch of its latest dermal filler called the Belotero Revive dermal filler, a combination of hyaluronic acid and glycerolIn April 2019, ALLERGAN announced the launch of Juvéderm VOLUX, a dermal filler aimed at the refinement of the chin and jawlineIn December 2016, Galderma laboratories announced the FDA approval of Restylane Refyne and Restylane Defyne dermal fillers for the treatment of laugh lines
Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/dermal-fillers-market-100939
Demand for Dermal Fillers to Rise Among Millennials Propelling Growth in the MarketGrowing aging population across the world positively impacts the growth of the market. Increasing number of aged people are undergoing dermal filler therapy to uplift drooping skin and restore lost volume. Continuous support from governments to R&D initiatives and recent regulatory approvals will spur growth in the market.North America Leads Gains Owing to Growing Demand for Advanced Dermal FillersIn 2018, the market in North America was worth US$ 1,596.8 Mn. Driven by the growing demand for innovative and advanced dermal fillers, the region is expected to lead global market through the forecast years.
To get to know more about the short-term & long-term impact of COVID-19 on this market, please click here: https://www.fortunebusinessinsights.com/industry-reports/dermal-fillers-market-100939
As per a study conducted by ASPS, more than 2 million people in the U.S. underwent hyaluronic acid procedures. Increasing awareness about soft tissue fillers treatment in the U.S. is expected to drive the market in North America. Extensive availability of products in this region is positively impacting the growth of the market.Apart from North America, the market in Asia Pacific is also growing substantially in the forecast years. The rising demand for aesthetics in China and India is creating growth opportunities for the market in Asia Pacific.
Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/dermal-fillers-market-100939
Product Launches by Market Players to Accelerate the Market GrowthThe report profiles some of the key players in the global dermal fillers market. These include BioPlus Co., Ltd., Galderma laboratories, Bioxis pharmaceuticals, Suneva Medical, DR. Korman, Sinclair Pharma, ALLERGAN, Merz Pharma, and CANDELA CORPORATION. Among these, ALLERGAN was leading the global market in 2018 encompassing a large number of specialized and technologically-advanced products.The company offers a JUVÉDERM collection of dermal fillers, which includes lip enhancement and wrinkles correction. Moreover, the company launched Juvéderm VOLUX to reduce fines lines on jawline and chin. Another company called Merz Pharma recently launched a dermal filler product called Belotero Revive to meet the unique skin requirements of aesthetic patients. Such product launches are expected to help companies broaden their product portfolio, which will stimulate growth in the market.
Get your Customized Research Report: https://www.fortunebusinessinsights.com/enquiry/customization/dermal-fillers-market-100939
Key companies covered in the report:ALLERGANMerz PharmaGalderma laboratoriesSinclair PharmaBioPlus Co., Ltd.Bioxis pharmaceuticalsSCULPT Luxury Dermal Fillers LTDDR. KormanProllenium Medical TechnologiesCANDELA CORPORATIONSuneva MedicalAnika Therapeutics, Inc
Quick Buy –  Dermal Fillers Market Research Report: https://www.fortunebusinessinsights.com/checkout-page/100939
Global Dermal Fillers Market Segmentation:By Product           •              Biodegradable•              Non-BiodegradableBy Ingredient      •              Hyaluronic Acid•              Calcium Hydroxylapatite•              Poly-L-lactic Acid•              PMMA (Poly(methyl methacrylate))•              Fat Fillers•              OthersBy Application     •              Scar Treatment•              Wrinkle Correction Treatment•              Lip Enhancement•              Restoration of Volume/ Fullness•              OthersBy End User         •              Specialty & Dermatology Clinics•              Hospitals & Clinics•              OthersBy Geography      •              North America (U.S., and Canada)•              Europe (Germany, U.K., France, Italy, Spain, Scandinavia, and Rest of Europe)•              Asia Pacific (China, India, Japan, Australia, South East Asia, and Rest of Asia Pacific)•              Latin America (Brazil, Mexico, and the Rest of Latin America)•              Middle East & Africa (GCC, South Africa, and Rest of Middle East & Africa)
Inquire Before Buying: https://www.fortunebusinessinsights.com/enquiry/queries/dermal-fillers-market-100939
SECONDARY RESEARCH IS CONDUCTED TO DERIVE THE FOLLOWING INFORMATION:Details such as revenues, market share, strategies, growth rate, product & their pricing by region/country for all major companiesDetails in relation to prevalence, incidence, patient numbers, distribution of patients, average price of treatment, etc.Number of end user facilities by region/country and average annual spending or procurement of devices by type of end user facilityNumber of procedures and average price of proceduresReplacement rate and pricing of capital equipmentMarket dynamics in relation to the market under focus – Drivers, restraints, trends, and opportunitiesMarket & technological trends, new product developments, product pipeline.
Have a Look at Related Reports:Orthopedic Implants Market Share & Industry Analysis, By Product (Joint Reconstruction; Spinal Implants; Trauma Implants, Dental Implants; Orthobiologics, and Others) End-user (Hospitals, Orthopedic Clinics, Ambulatory Surgical Centers, and Others) and Regional Forecast, 2019-2026U.S. Secondary Hyperparathyroidism (SHPT) Treatment Market Share & Industry Analysis, By Drug Class (Calcimimetics, Vitamin D Analogues, and Phosphate Binders), By Distribution Channel (Hospital & Retail Pharmacies, Online Channels, and Others), and Region Forecast 2019-2026Urinary Catheter Market Share & Industry Analysis, By Product (Indwelling Catheters, Intermittent Catheters, and External Catheters), By Application (Urinary Incontinence, Benign Prostatic Hyperplasia (BPH), Surgery, and Others), By Gender (Female, Male), By End User (Hospitals, Age Care Centers, and Others) and Regional Forecast 2019-2026Subdural Electrode Market Share & Industry Analysis, By Type (Strip, Grid, Depth, and Others) By Material (Platinum and Stainless Steel) By End User (Hospitals, Specialty Clinics, and Others) and Regional Forecast, 2019-2026Immune Thrombocytopenia (ITP) Market Share & Industry Analysis, By Type (Acute Immune Thrombocytopenia, and Chronic Immune thrombocytopenia), By Treatment (Thrombopoietin Receptor Agonist, Immunoglobulins, Corticosteroids, and Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Others) and Regional Forecast, 2019-2026
About Us:Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.
Contact Us:Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune – 411045, Maharashtra, India.Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: sales@fortunebusinessinsights.com
Fortune Business Insights™
LinkedIn | Twitter | Blogs
Press Release: https://www.fortunebusinessinsights.com/press-release/dermal-fillers-market-9173

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.